Levaquin, Levofloxacin Newswire

Levaquin, Levofloxacin Newswire

Comprehensive Real-Time News Feed for Levaquin, Levofloxacin (generic).

Results 1 - 20 of 100 in Levaquin, Levofloxacin (generic)

  1. AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of...Read the original story w/Photo

    3 hrs ago | US Recall News

    AuroMedics Pharma LLC is voluntarily recalling one lot of Levofloxacin in 5% Dextrose Injection 250mg/50mL in a Single-Use flexible container NDC 55150-243-46, Lot CLF160003, Expiry date May 2018, to the hospital level. The product has been found to contain visible particulate matter tentatively identified as mold.


  2. In vitro antimicrobial susceptibility testing of human Brucella...Read the original story w/Photo

    Monday | BioMed Central

    Brucellosis is an endemic disease in the Inner Mongolia Autonomous Region of China and Ulanqab exhibits the highest prevalence of brucellosis in this region. Due to the complex nature of Brucellosis, a cure for this disease has proven to be elusive.


  3. The Relevance of Febrile Neutropenia in OncologyRead the original story w/Photo

    Friday Dec 29 | The American Journal of Managed Care

    Febrile neutropenia is among the most serious clinical complications in patients with cancer who are undergoing chemotherapy. Patients with neutropenia, or low neutrophil counts, are predisposed to serious and life-threatening infections because of their immune system's impaired ability to mount inflammatory responses to bacteria, fungi, and yeast.1,2 Because fever is often the only sign of infection in these patients, the presence of both fever and neutropenia must be treated as a medical emergency.2,3 Despite advances in treatment and prevention, mortality rates in patients with cancer and FN can range from 5% to 20%.


  4. Streptococcus agalactiae infective endocarditis complicated by...Read the original story w/Photo

    Thursday Dec 28 | BioMed Central

    The burden of disease caused by Streptococcus agalactiae has increased significantly among older adults in the last decades. Group B streptococcus infection can be associated with invasive disease and severe clinical syndromes, such as meningitis and endocarditis.


  5. Case StudiesRead the original story

    Thursday Dec 28 | Pharmacy Times

    Case 1 JM is a 68-year-old woman who is given a diagnosis of cellulitis on her left calf by a medical resident. JM has a medical history of hypertension, chronic obstructive pulmonary disease, and heart failure, as well as a urinary tract infection that was treated with levofloxacin 2 weeks ago.


  6. Head-To-Head Survey: Horizon PharmaRead the original story w/Photo

    Sunday Dec 24 | Daily Political

    Horizon Pharma and Akorn are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability. 86.6% of Horizon Pharma shares are owned by institutional investors.


  7. Epididymitis: An Overview.Read the original story

    Thursday Dec 21 | CiteULike

    Inflammation of the epididymis, or epididymitis, is commonly seen in the outpatient setting. Etiology and treatment are based on patient age and the likely causative organisms.


  8. Two cases of progressive cutaneous anthrax describedRead the original story w/Photo

    Wednesday Dec 20 | PhysOrg Weblog

    Two cases of cutaneous anthrax which started on the right forearm and progressed are described in a case report published online Dec. 12 in the International Journal of Dermatology . Hai-Ling Yuan, from Lanzhou General Hospital in China, and colleagues present two cases of human cutaneous anthrax that began in the right forearm and progressed.


  9. Whole-Genome Analysis of Recurrent Staphylococcus aureus t571/ST398 Infection in Farmer, Iowa, USARead the original story

    Tuesday Dec 19 | Centers for Disease Control and Prevention

    Wardyn SE, Stegger M, Price LB, Smith TC. Whole-Genome Analysis of Recurrent Staphylococcus aureus t571/ST398 Infection in Farmer, Iowa, USA.


  10. Head to Head Survey: Horizon PharmaRead the original story w/Photo

    Dec 17, 2017 | AmericanBankingNews.com

    Horizon Pharma and Akorn are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations and institutional ownership. This is a breakdown of recent ratings and price targets for Horizon Pharma and Akorn, as provided by MarketBeat.com.


  11. Critical Review: Horizon PharmaRead the original story w/Photo

    Dec 17, 2017 | Daily Political

    Horizon Pharma and SciClone Pharmaceuticals are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings. SciClone Pharmaceuticals has lower revenue, but higher earnings than Horizon Pharma.


  12. Dengue death: Fortis kept profit margin as high as 1,737 per cent, finds NPPARead the original story w/Photo

    Dec 15, 2017 | The Indian Express

    NPPA had asked Fortis to furnish details of procurement and billing prices of all items it had used while treating the girl. Fortis Hospital, Gurgaon made a 1,737 per cent profit on drugs and other consumables that it billed the family of seven-year-old Aadya Singh, the drug pricing regulator has found in an analysis.


  13. U.S. Bacterial Conjunctivitis Drugs Market: Segmental Highlights and Table of ContentRead the original story w/Photo

    Dec 11, 2017 | SBWire

    According to Transparency Market Research, the U.S. bacterial conjunctivitis drugs market will be worth US$439.8 mn by 2024. This will be a decrease from the previous years as the generic variants encroach the market of bacterial conjunctivitis drugs.


  14. Case StudiesRead the original story

    Nov 28, 2017 | Pharmacy Times

    Case 1 MJ is a 67-year-old woman who presents to the emergency department complaining of abdominal pain and frequent diarrhea for the past 3 days. She also reports loss of appetite and is febrile, with a temperature of 101.1oF.


  15. A comparison of different antibiotic regimens for the treatment of infective endocarditisRead the original story

    Nov 25, 2017 | CiteULike

    Background Infective endocarditis is a microbial infection of the endocardial surface of the heart. Antibiotics are the cornerstone of treatment, but their use is not standardised, due to the differences in presentation, populations affected and the wide variety of micro-organisms that can be responsible.


  16. 5 Things Pharmacists Should Know About Legionnaires DiseaseRead the original story

    Nov 5, 2017 | Pharmacy Times

    Jennifer Gershman, PharmD, CPh, received her PharmD degree from Nova Southeastern University College of Pharmacy in 2006 and completed a 2-year drug information residency. She served as a pharmacy professor at NSUa TMs College of Pharmacy for 6 years, managed the drug information center, and conducted medication therapy management reviews.


  17. Cipro and Life Altering Side EffectsRead the original story w/Photo

    Nov 15, 2017 | OpEdNews

    Cipro is a popular broad-based spectrum antibiotic widely used by many doctors to treat bacterial infections like sinus infections, uncomplicated Urinary Tract Infections and bronchitis. It is part of the fluoroquinolones family that includes generic ciprofloxacin , gemifloxacin , levofloxacin , moxifloxacin , norfloxacin , and ofloxacin .


  18. Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysisRead the original story w/Photo

    Nov 13, 2017 | BioMed Central

    Multidrug-resistant tuberculosis is a threat for the global TB epidemic control. Despite existing evidence that individualized treatment of MDR-TB is superior to standardized regimens, the latter are recommended in Brazil, mainly because drug-susceptibility tests are often restricted to first-line drugs in public laboratories.


  19. Urinary Tract Infection (UTI) Treatment Market to Discern Magnified Growth During 2016 - 2026Read the original story w/Photo

    Nov 13, 2017 | SBWire

    Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections , whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients.


  20. U.S. Bacterial Conjunctivitis Drugs Market to Be Worth US $439.8 Mn by 2024Read the original story w/Photo

    Nov 9, 2017 | SBWire

    Bacterial conjunctivitis is a commonly encountered eye problem across the world, caused by various bacterial strains such as streptococci, staphylococci, chlamydial, and gonococci organisms. Majority of the cases of bacterial conjunctivitis are self-limited and acute and not a major cause of morbidity.